Mattia Galli/LinkedIn
Dec 19, 2025, 12:07
OCEAN Trial: Rethinking Long-term Anticoagulation after Atrial Fibrillation Ablation
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, posted on LinkedIn:
”Can we drop oral anticoagulant therapy after successful atrial fibrillation ablation?”
Read the full article here.
Title: OCEAN trial: rethinking long-term anticoagulation after atrial fibrillation ablation
Authors: Mattia Galli, Beatrice Simeone, Sebastiano Sciarretta
Stay updated with Hemostasis Today.
Anticoagulation
Atrial Fibrillation
Atrial Fibrillation Ablation
Beatrice Simeone
Cardiology
ESC
European Heart Journal
European Society of Cardiology
Health
Heart Health
Hematology
Hemostasis
Hemostasis Today
Long-term Anticoagulation
Mattia Galli
Medicine
OCEAN Trial
Sapienza University of Rome
Sebastiano Sciarretta
thrombosis
-
Apr 9, 2026, 19:13Jan Sloves: Patterns and Pitfalls Influencing Treatment of Small Saphenous Vein Reflux
-
Apr 9, 2026, 18:38Jecko Thachil: Why D-dimers are Useful Tests for the Exclusion of Thromboembolism and the Diagnosis of DIC
-
Apr 9, 2026, 18:21New Clinical Practice Guideline on Anticoagulant Prophylaxis in Pediatric Patients at Risk of VTE – ISTH
-
Apr 9, 2026, 16:40We Are Incredibly Grateful to Our Volunteers – Hemophilia of Georgia
-
Apr 9, 2026, 15:10Christoffer Gebhardt: Can Anticoagulation Improve Outcomes in Melanoma Therapy?
-
Apr 9, 2026, 15:09National Institutes of Health Addresses VTE Research Funding Gap – JTH
-
Apr 9, 2026, 15:08Alice Assinger: Recruiting PhD Students for NET-IT Doctoral Program in Vienna
-
Apr 9, 2026, 15:07Hannah Cohen: A Novel Approach to Post-Stroke Gait Rehabilitation
-
Apr 9, 2026, 15:07Shehab Mohamed: A Single-Center Experience on Stroke Risk in Polycythemia Vera